APPLICATION
ANDA090923
TYPE
ANDA
ORIGINAL APPROVAL
2013-04-02
LATEST ACTION
2020-04-11
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
AZITHROMYCINDiscontinued
AZITHROMYCIN EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-04-11Labeling · Supplement 8 · standardAP
2020-04-11Labeling · Supplement 9 · standardAP
2020-04-11Labeling · Supplement 15 · standardAP
2017-02-01Labeling · Supplement 7 · standardAP
2015-03-19Labeling · Supplement 2 · standardAP
2013-04-02OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.